| Digitoxigenin | 143-62-4 | C23H34O4 |
| Digitoxin for LC assay | 71-63-6 | C41H64O13 |
| Diglycidyl Ether | 2238-07-5 | C6H10O3 |
| Digoxigenin Bisdigitoxoside | 5297-05-2 | C35H54O11 |
| Digoxigenin Monodigitoxoside | 5352-63-6 | C29H44O8 |
| Digoxigenin Tetradigitoxoside | 31539-05-6 | C47H74O17 |
| Digoxin EP Impurity A | 71-63-6 | C41H64O13 |
| Digoxin EP Impurity D | 5352-63-6 | C29H44O8 |
| Digoxin EP Impurity F | 5297-05-2 | C35H54O11 |
| Digoxin EP Impurity J | 5355-48-6 | C43H66O15 |
| Digoxin EP Impurity K | 31539-05-6 | C47H74O17 |
| Digoxin for peak identification | 20830-75-5 | C41H64O14 |
| Digoxin Impurity 2 | 5297-10-9 | C41H66O14 |
| Dihydralazine impurity 3 | 649765-80-0 | C8H9N5 |
| Dihydro Artemisinic Aldehyde | 125184-93-2 | C15H24O |
| Dihydro Cyclosporin D | 63775-91-7 | C63H115N11O12 |
| Dihydro Donepezil (mixture of diastereomers) | 120012-04-6 | C24H31NO3 |
| Dihydro Dutasteride | 164656-22-8 | C27H32F6N2O2 |
| Dihydro Finasteride | 98319-24-5 | C23H38N2O2 |
| Dihydro Montelukast | 142147-67-9 | C35H38ClNO3S |
| Dihydro Montelukast Sodium Salt | 142147-98-6 | C35H37ClNNaO3S |
| Dihydro Montelukast Sodium Salt | 142147-98-6 | C35H37ClNNaO3S |
| Dihydro Mupirocin | Not available | C26H46O9 |
| Dihydro Progesterone | 566-65-4 | C21H32O2 |
| Dihydro Simvastatin | Not available | C25H40O5 |
| Dihydro Uracil | 504-07-4 | C4H6N2O2 |
| dihydro-9H-purin-9-yl)methoxy]ethyl | 102728-64-3 | C10H13N5O4 |
| Dihydro-lovastatin | 77517-29-4 | C24H38O5 |
| Dihydroberberine | 483-15-8 | C20H19NO4 |
| Dihydrochloride | Not available | C18H25Cl2N9O4S3 |
| Dihydrociclosporin A | 59865-15-5 | C62H113N11O12 |
| Dihydrocodeine Hydrogen Tartrate Imp. A (EP) as Monohydrate: Codeine Monohydrate | 6059-47-8 | C18H23NO4 |
| Dihydrocodeine Hydrogen Tartrate Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate | 41444-62-6 | C36H50N2O15P2 |
| Dihydrocodeine Hydrogen Tartrate Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate | 6211-15-0 | C34H50N2O15S |
| Dihydrocodeine Hydrogen Tartrate Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate | Not available | C17H26ClNO6 |
| Dihydrocodeine N-Oxide | 109667-32-5 | C18H23NO4 |
| Dihydrodiol Ibrutinib | 1654820-87-7 | C25H26N6O4 |
| Dihydroergotamine EP impurity D | 5550-75-4 | C33H37N5O5 |
| Dihydrofinasteride | 98319-24-5 | C23H38N2O2 |
| Dihydrogalantamine | 89505-76-0 | C17H24BrNO3 |
| dihydroiso-benzofuran-5-yl)-4-methylhex-4-enoate (Methyl Mycophenolate) | 31858-66-9 | C18H22O6 |
| dihydropyridin-1(2H)-yl]-N,N-dimethyl-2,2- diphenylbutanamide | 61299-42-1 | C29H31ClN2O |
| Dihydropyrimidine-2,4,5(3H)-trione (Isobarbituric Acid; 5-Hydroxyuracil) | 496-76-4 | C4H4N2O3 |
| Dihydrospectinomycin | 28048-39-7 | C14H26N2O7 |
| Dihydrotachysterol for system suitability | 67-96-9 | C28H46O |
| Dihydrotestosterone Impurity 1 | Not available | C26H42O3 |
| Dihydrotriazine | 1347860-96-1 | C3H5N3 |
| Dihydrovinpocetine | Not available | C22H28N2O2 |
| Dihydroxy Bendamustine Sodium Salt | Not available | C16H22N3NaO4 |
| Dihydroxy Oxaliplatin-Pt(IV) | 111321-67-6 | C8H16N2O6Pt |
| Dihydroxyacetone Phosphate Lithium Salt | Not available | C2H5O6P |
| Diisobutyl Phosphate-d14 | Not available | C8H19O4P |
| Diisopropyl ([(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl)phosphonate | 160616-04-6 | C15H26N5O4P |
| Diisopropyl [((2R)-1-(6-Benzoylamino-9H-purin-9-yl)propan-2-yloxy)methyl]phosphonate | 627510-49-0 | C22H30N5O5P |
| Diisopropyl Bicarbamate | 19740-72-8 | C8H16N2O4 |
| Diisopropyl Cromoglicate | Not available | C29H28O11 |
| Diisopropyl Cromoglicate | 2726144-87-0 | C29H28O11 |
| Diisopropyl Hydrazine-1,2-dicarboxylate | 19740-72-8 | C8H16N2O4 |
| Diisopropyl Hydrazine-1,2-dicarboxylate | 19740-72-8 | C8H16N2O4 |
| Diisopropylhomoveratrylcyanide | 51698-54-5 | C16H23NO2 |
| Diisopyronitrile Dihydrogen Phosphate | 2724689-67-0 | C21H30N3O4P |
| Diltiazem Enantiomer HCl | 42399-54-2 | C22H27ClN2O4S |
| Diltiazem EP Impurity A | 111188-71-7 | C22H26N2O4S |
| Diltiazem EP Impurity A HCl | 103532-27-0 | C22H27ClN2O4S |
| Diltiazem EP Impurity B | 87447-47-0 | C18H17NO4S |
| Diltiazem EP Impurity B HCl | 1286126-67-7 | C21H25ClN2O4S |
| Diltiazem EP Impurity D | 130606-60-9 | C21H25ClN2O4S |
| Diltiazem EP Impurity E | 42399-49-5 | C16H15NO3S |
| Diltiazem EP Impurity F | 42399-40-6 | C20H24N2O3S |
| Diltiazem EP Impurity F HCl | 75472-91-2 | C20H25ClN2O3S |
| Diltiazem EP Impurity F-D4 | 112259-40-2 | C20H24N2O3S |
| Diltiazem EP Impurity G (Rac) | 81353-09-5 | C19H22N2O3S |
| Diltiazem for system suitability | 33286-22-5 | C22H27ClN2O4S |
| Diltiazem Hydrochloride Imp. B (EP): (2S,3S)-2-(4-Methoxyphenyl)- 4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin- 3-yl Acetate | 87447-47-0 | C18H17NO4S |
| Diltiazem Hydrochloride Imp. D (EP) as Hydrochloride: (2S,3S)-2-(4- Methoxyphenyl)-5-[2-(methylamino)ethyl]-4- oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin- 3-yl Acetate Hydrochloride (N-Desmethyl- diltiazem Hydrochloride) | 130606-60-9 | C21H25ClN2O4S |
| Diltiazem Hydrochloride Imp. E (EP): (2S,3S)-3-Hydroxy-2-(4- methoxyphenyl)-2,3-dihydro-1,5- benzothiazepin-4(5H)-one | 42399-49-5 | C16H15NO3S |
| Diltiazem Hydrochloride Imp. F (EP): (2S,3S)-5-[2-(Dimethylamino)- ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3- dihydro-1,5-benzothiazepin-4(5H)-one | 42399-40-6 | C20H24N2O3S |
| Diltiazem Impurity 1 | 116050-35-2 | C20H23ClN2O4S |
| Diltiazem Impurity 2 | 111188-70-6 | C22H26N2O4S |
| Diltiazem Impurity 4 | 132830-17-2 | C16H15NO3S |
| Diltiazem Impurity 5 | 91926-66-8 | C20H24N2O3S |
| Diltiazem Impurity 22 | 625471-04-7 | C11H22N2O2 |
| Diltiazem Impurity 23 | 137173-40-1 | C11H12O4 |
| Diltiazem impurity F | 160141-19-5 | C9H18ClNO2 |
| Diltiazem impurity standard | 33286-22-5 | C22H27ClN2O4S |
| Diltiazem Maleate | 139492-78-7 | C26H30N2O8S |
| Diltiazem Sulfoxide Impurity | 370094-12-5 | C22H26N2O5S |
| Diltiazem Sulphoxide | 370094-12-5 | C22H26N2O5S |
| Dimenhydrinate for peak identification | 523-87-5 | C24H28ClN5O3 |
| Dimenhydrinate Imp. A (EP): Theophylline | 58-55-9 | C7H8N4O2 |
| Dimenhydrinate Imp. C (EP): Caffeine | Not available | C8H10N4O2 |
| Dimenhydrinate Imp. E (EP): 8-Chloro-1,3,7-trimethyl-3,7- dihydro-1H-purine-2,6-dione (8-Chlorocaffeine) | 4921-49-7 | C8H9ClN4O2 |
| Dimenhydrinate Imp. F (EP) as Hydrochloride: 2-(Diphenyl- methoxy)-N-methylethanamine Hydrochloride (Diphenhydramine Imp. A Hydrochloride; Nordiphenhydramine Hydrochloride) | 53499-40-4 | C16H20ClNO |
| Dimenhydrinate Imp. G (EP) as Hydrochloride: N,N-Dimethyl- 2-[(RS)-(4-methylphenyl)(phenyl)methoxy]- ethanamine Hydrochloride (4-Methyldiphen- hydramine Hydrochloride) | 4024-34-4 | C18H24ClNO |
| Dimenhydrinate Imp. H (EP) as Hydrochloride: 2-[(RS)-(4- Bromophenyl)(phenyl)methoxy]-N,N-dimethyl- ethanamine Hydrochloride (4-Bromodiphen- hydramine Hydrochloride; Bromazine Hydro- chloride) | 1808-12-4 | C17H21BrClNO |
| Dimenhydrinate Imp. I (EP): Diphenylmethanol (Benzhydrol) | 91-01-0 | C13H12O |
| Dimenhydrinate Imp. J (EP): Diphenylmethanone (Benzophenone) | 119-61-9 | C13H10O |
| Dimenhydrinate Imp. K (EP): [Oxybis(methanetriyl)]tetrabenzene (Bis(diphenylmethyl) Ether) | 574-42-5 | C26H22O |
| Dimenhydrinate Related Compound E | 4921-49-7 | C8H9ClN4O2 |
| Dimepheptanol | 545-90-4 | C21H29NO |
| Dimesna | 16208-51-8 | C4H8Na2O6S4 |
| dimethoxy-1H-indene-1,3(2H)-dione) | 1023500-88-0 | C24H27NO4 |
| dimethoxybenzyl)pyrimidin-4-ol N4-Methyl-5-(3,4,5-trimethoxybenzyl)- | 72920-13-9 | C13H15N3O4 |
| Dimethyl 2,6-Dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate | 67035-22-7 | C17H16N2O6 |
| Dimethyl 2,6-Dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (Nitrophenylpyridine Analogue of Nifedipine) | 67035-22-7 | C17H16N2O6 |
| Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylate | 50428-14-3 | C17H16N2O5 |
| Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylate | 50428-14-3 | C17H16N2O5 |
| Dimethyl 2,6-Dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate (Nitrosophenylpyridine Analogue of Nifedipine) | 50428-14-3 | C17H16N2O5 |
| Dimethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 21881-77-6 | C17H18N2O6 |
| Dimethyl 2-(1,3-Dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)pentanedioate | 827026-43-7 | C15H16N2O7 |
| Dimethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 91189-59-2 | C17H17Cl2NO4 |
| Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 43067-01-2 | C17H18ClNO4 |
| Dimethyl (4RS)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 140171-66-0 | C19H23ClN2O5 |
| Dimethyl Cromoglicate | 51471-26-2 | C25H20O11 |
| Dimethyl Fumarate Dimer | 14495-41-1 | C12H16O8 |
| Dimethyl Isosorbide | 5306-85-4 | C8H14O4 |
| Dimethyl L-Glutamate Hydrochloride | 23150-65-4 | C7H14ClNO4 |
| Dimethyl Pseudomorphine | 121395-47-9 | C36H40N2O6 |
| Dimethyl-2,6-Dimethyl-4-(2-Nitrophenyl) Pyridine-3,5-Dicarboxylate | 67035-22-7 | C17H16N2O6 |
| Dimethyl-2,6-Dimethyl-4-(2-Nitrosophenyl) Pyridine-3,5-Dicarboxylate | 50428-14-3 | C17H16N2O5 |
| Dimethyl-2,6-Dimethyl-4-(2-Nitrosophenyl) Pyridine-3,5-Dicarboxylate | 50428-14-3 | C17H16N2O5 |
| Dimethyl-(tetrahydro-3,3-diphenyl-2- furilidine)ammonium Bromide | 37743-18-3 | C18H20BrNO |
| Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine)ammonium Bromide | 37743-18-3 | C18H20BrNO |
| Dimethylaminoacetaldehyde | 52334-92-6 | C4H9NO |
| Dimethylaminomethylfurylmethylthioethyl Ranitidine | 72126-78-4 | C22H35N5O4S2 |
| Dimethylaminopropanol acetate aminobenzoate | 61990-51-0 | C14H22N2O4 |
| Dimethylammonium dimethylcarbamate | 4137-10-4 | C5H14N2O2 |
| Dimethylbenzamide reference substance | 6526-67-6 | C9H10ClNO |
| Dimethyldodecylamine | 112-18-5 | C14H31N |
| Dimethylinderidine maleate | 3614-69-5 | C24H28N2O4 |
| Dimethyl{5-[2-(1-Methylamino-2-Nitrovinylamino)Ethylsulfinylmethyl]Furfuryl}Amine | 73851-70-4 | C13H22N4O4S |
| Dimetindene Maleate Imp. A (EP): 2-Ethylpyridine | 100-71-0 | C7H9N |
| Dimetindene Maleate Imp. B (EP) as Hydrochloride: 2-(1H-Inden- 2-yl)-N,N-dimethylethanamine Hydrochloride | 92039-35-5 | C13H18ClN |
| Dimetindene Maleate Imp. E (EP) as Hydrochloride: (2RS)-2-[2-(Dimethyl- amino)ethyl]indan-1-one Hydrochloride | 5143-99-7 | C13H18ClNO |
| Dimetindene Maleate Imp. G (EP) as Hydrochloride: N,N-Dimethyl- 2-(3-phenyl-1H-inden-2-yl)ethanamine Hydro- chloride | Not available | C19H22ClN |
| Dimetindene Maleate Imp. I (EP) as Maleate: N-Methyl-2-[3-[(1RS)- 1-(pyridin-2-yl)ethyl]-1H-inden-2-yl]ethanamine Maleate | 135784-57-5 | C23H26N2O4 |
| Dimetindene N-Oxide Dihydrochloride | Not available | C20H26Cl2N2O |
| Dimetol | 139306-10-8 | C10H15NO |
| Dimetridazole-2-hydroxy | 936-05-0 | C5H7N3O3 |
| Dinitolmide Impurity A | 1975-52-6 | C8H7NO4 |
| Dinitolmide Impurity B | 28169-46-2 | C8H6N2O6 |
| Dinitolmide Impurity C | 50825-99-5 | C8H8N2O3 |
| Dinitolmide Impurity E | 948-31-2 | C8H5N3O4 |
| Dinoprost trometamol EP Impurity A | 36150-01-3 | C20H34O5 |
| Dinoprost trometamol EP ImpurityB | 37658-84-7 | C20H34O5 |
| Dinoprostone EP Impurity D | 13345-50-1 | C20H30O4 |
| Dinoprostone impurity C | 36150-00-2 | C20H32O5 |
| Dinoprostone Related Compound C | 36150-00-2 | C20H32O5 |
| Dioctadecyl Disulfide | 2500-88-1 | C36H74S2 |
| dione | 28888-44-0 | C10H10N2O4 |
| Diosmetin | 520-34-3 | C16H12O6 |
| DiosMetin 3-O-β-D-Glucuronide | 152503-50-9 | C22H20O12 |
| Diosmetin (Diosmin EP Impurity F) | 520-34-3 | C16H12O6 |
| Diosmin EP Impurity A | 6100-74-9 | C9H10O3 |
| Diosmin EP Impurity D | 1431536-92-3 | C28H31IO15 |
| Diosmin EP Impurity E (Linarin) | 480-36-4 | C28H32O14 |
| Diosmin for system suitability | 520-27-4 | C28H32O15 |
| Diosmin Imp. B (EP): (2S)-7-[[6-O-(6-Deoxy- -L- mannopyranosyl)- -D-glucopyranosyl]oxy]- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)- 2,3-dihydro-4H-1-benzopyran-4-one (Hesperidin) | 520-26-3 | C28H34O15 |
| Diosmin Impurity 9 | 38302-15-7 | C18H18O5 |
| Diosmin Impurity 10 | 89294-54-2 | C17H16O6 |
| Diosmin Impurity 11 | 28719-21-3 | C30H38O15 |
| Diosmin Impurity 14 | 115960-14-0 | C30H36O16 |
| Diosmin Impurity 19 | 645-08-9 | C8H8O4 |
| Diosmin-7-O-beta-D-Glucoside | 20126-59-4 | C22H22O11 |
| Dioxypyramidon | 519-65-3 | C13H17N3O3 |
| Diphenhydramine | 58-73-1 | C17H21NO |
| Diphenhydramine EP Impurity A (Dimenhydrinate EP Impurity F) | 17471-10-2 | C16H19NO |
| Diphenhydramine EP Impurity A HCl | 53499-40-4 | C16H20ClNO |
| Diphenhydramine EP Impurity B (Dimenhydrinate EP Impurity G/Orphenadrine EP Impurity F) | 19804-27-4 | C18H23NO |
| Diphenhydramine EP Impurity B HCl | 4024-34-4 | C18H24ClNO |
| Diphenhydramine EP Impurity C (Dimenhydrinate EP Impurity H) | 118-23-0 | C17H20BrNO |
| Diphenhydramine EP Impurity C HCl | 1808-12-4 | C17H21BrClNO |
| Diphenhydramine EP Impurity D (Dimenhydrinate EP Impurity I/Ebastine EP Impurity A) | 91-01-0 | C13H12O |
| Diphenhydramine EP Impurity E (Dimenhydrinate EP Impurity J/Phenytoin EP impurity A) | 119-61-9 | C13H10O |
| Diphenhydramine HCl | 147-24-0 | C17H22ClNO |
| Diphenhydramine Hydrochloride Imp. A (EP) as Hydrochloride: 2-(Diphenyl- methoxy)-N-methylethanamine Hydrochloride (Nordiphenhydramine Hydrochloride) | 53499-40-4 | C16H20ClNO |
| Diphenhydramine Hydrochloride Imp. B (EP) as Hydrochloride: 2-[(RS)- (4-Methylphenyl)phenylmethoxy]-N,N- dimethylethanamine Hydrochloride (4-Methyldiphenhydramine Hydrochloride) | 4024-34-4 | C18H24ClNO |
| Diphenhydramine Hydrochloride Imp. C (EP) as Hydrochloride: 2-[(RS)- (4-Bromophenyl)phenylmethoxy]-N,N- dimethylethanamine Hydrochloride (Bromazine Hydrochloride) | 1808-12-4 | C17H21BrClNO |
| Diphenhydramine Hydrochloride Imp. D (EP): Diphenylmethanol (Benzhydrol) | 91-01-0 | C13H12O |
| Diphenhydramine Hydrochloride Imp. E (EP): Diphenylmethanone (Benzophenone) | 119-61-9 | C13H10O |
| Diphenhydramine impurity 1 | 31065-89-1 | C18H24BrNO |
| Diphenhydramine impurity 2 | 13168-00-8 | C17H22ClNO2 |
| Diphenhydramine Impurity 4 | 574-42-5 | C26H22O |
| Diphenhydramine Impurity 6 | 19574-66-4 | C16H18O3 |
| Diphenhydramine Impurity 7 | 21409-25-6 | C15H14O3 |
| Diphenhydramine impurity A | 17471-10-2 | C16H19NO |
| Diphenhydramine Impurity B | 4024-34-4 | C18H24ClNO |
| Diphenhydramine Methiodide | Not available | C18H24INO |
| Diphenhydramine N-Glucuronide | 137908-78-2 | C23H29NO7 |
| Diphenhydramine N-Oxide | 3922-74-5 | C17H21NO2 |
| Diphenhydramine N-Oxide Hydrochloride | 13168-00-8 | C17H22ClNO2 |
| Diphenoxylate EP impurity B | 4370-12-1 | C2H2N2O |
| Diphenoxylate EP impurity C | 39186-58-8 | C16H14BrN |
| Diphenoxylate HCl | 3810-80-8 | C30H33ClN2O2 |
| Diphenoxylate Related Compound A | 28782-42-5 | C28H28N2O2 |
| Diphenyl(piperidin-3-yl)methanol (Pipradrol 3-Isomer) | 88783-30-6 | C18H21NO |
| Diphenyl(piperidin-4-yl)methanol (Azacyclonol) | 115-46-8 | C18H21NO |
| Diphenyl(piperidin-4-yl)methanol (Azacyclonol; Pipradrol 4-Isomer) | 115-46-8 | C18H21NO |
| Diphenyl[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonyl)amino-pyrimidin-5-yl-methyl]phosphine Oxide | 289042-10-0 | C28H29FN3O3PS |
| Diphenylacetonitrile | 86-29-3 | C14H11N |
| Diphenylcarbamic Chloride | 83-01-2 | C13H10ClNO |
| Diphenylethanedione (Benzil) | 134-81-6 | C14H10O2 |
| Diphenylglycoluril | 5157-15-3 | C16H14N4O2 |
| Diphenylmethanol | 91-01-0 | C13H12O |
| Diphenylmethanol | 91-01-0 | C13H12O |
| Diphenylmethanol (Benzhydrol) | 91-01-0 | C13H12O |
| Diphenylmethanone | 119-61-9 | C13H10O |
| Diphenylmethanone (Benzophenone) | 119-61-9 | C13H10O |
| Diphenylphosphinic acid | 1707-03-5 | C12H11O2P |
| Diphenylpyraline N-Oxide | 10020-59-4 | C19H23NO2 |
| Dipivefrin (hydrochloride) | 64019-93-8 | C19H30ClNO5 |
| Dipivefrin Related Compound E | 64019-94-9 | C19H28ClNO5 |
| Dipivefrine for system suitability | 64019-93-8 | C19H30ClNO5 |
| Dipotassium 7-Hydroxy-1,3-naphthalenedisulfonate | 842-18-2 | C10H6K2O7S2 |
| Dipotassium Clorazepate Imp. A (EP): (2-Amino-5-chlorophenyl)phenyl- methanone (Aminochlorobenzophenone) | 719-59-5 | C13H10ClNO |
| Dipotassium Clorazepate Imp. B (EP): 7-Chloro-5-phenyl-1,3-dihydro- 2H-1,4-benzodiazepin-2-one (Nordazepam) | 1088-11-5 | C15H11ClN2O |
| Diprophylline Imp. A (EP): N-Methyl-5-(methylamino)-1H- imidazole-4-carboxamide (Theophyllidine) | 6736-40-9 | C6H10N4O |
| Diprophylline Imp. B (EP): 1,3-Dimethyl-3,7-dihydro-1H- purine-2,6-dione (Theophylline) | 58-55-9 | C7H8N4O2 |
| Diprophylline Imp. C (EP): 7-(2-Hydroxyethyl)-1,3-dimethyl- 3,7-dihydro-1H-purine-2,6-dione (Etofylline) | 519-37-9 | C9H12N4O3 |
| Diprophylline Imp. D (EP): 7-[(2RS)-2-Hydroxypropyl]-1,3- dimethyl-3,7-dihydro-1H-purine-2,6-dione (Proxyphylline) | 603-00-9 | C10H14N4O3 |
| Dipropylaminopretadalafil | Not available | C28H33N3O5 |
| Dipropylarticaine Hydrochloride | 2602451-77-2 | C16H27ClN2O3S |
| Dipyridamole EP Impurity A | 16982-40-4 | C25H40N8O2 |
| Dipyridamole EP Impurity B | 16908-47-7 | C23H40N8O6 |
| Dipyridamole EP Impurity C | 54093-92-4 | C20H30ClN7O2 |
| Dipyridamole EP Impurity D | 1176886-12-6 | C22H36N8O3 |
| Dipyridamole EP Impurity E | 2365420-11-5 | C24H40N8O4 |
| Dipyridamole EP Impurity F | 60286-30-8 | C21H36N8O5 |
| Dipyridamole EP Impurity G | 7139-02-8 | C16H20Cl2N6 |
| Dipyridamole for peak identification | 58-32-2 | C24H40N8O4 |
| Dipyridamole Imp. C (EP): 2,2'-[[6-Chloro-4,8-di(piperidin-1- yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo]diethanol | 54093-92-4 | C20H30ClN7O2 |
| Dipyridamole Impurity 1 | 6713-54-8 | C6H4N4O4 |
| Dipyridamole Impurity 2 | 32980-71-5 | C6Cl4N4 |
| Dipyridamole Impurity 3 | 36926-31-5 | C16H20Cl2N6 |
| Dipyridamole Impurity 4 | 60288-38-2 | C24H40N8O4 |
| Dipyridamole Impurity 5 | 68006-07-5 | C19H31N7O5 |
| Dipyridamole impurity standard | 58-32-2 | C24H40N8O4 |
| Dipyridamole Related Compound A | 16982-40-4 | C25H40N8O2 |
| Dipyridamole Related Compound B | 16908-47-7 | C23H40N8O6 |
| Dipyridamole Related Compound C | 54093-92-4 | C20H30ClN7O2 |
| Dipyridamole Related Compound D | 1176886-12-6 | C22H36N8O3 |
| Dipyridamole Related Compound F | 60286-30-8 | C21H36N8O5 |
| Diquafosmin sodium impurity 54 | 15718-50-0 | C9H10N2NaO8P |
| Diquafosol Impurity 1 | 211448-70-3 | C18H27N4O26P5 |
| Diquafosol Impurity 2 | 63785-59-1 | C18H25N4O20P3 |
| Diquafosol Impurity 3 | 26184-65-6 | C18H24N4O17P2 |
| Diquafosol Impurity 4 | 1402828-42-5 | C9H11N2Na5O18P4 |
| Diquafosol Impurity 6 | 63700-19-6 | C15H19N2Na3O18P2 |
| Diquafosol Impurity 8 | 10003-94-8 | C9H16N2O18P4 |
| Diquafosol Impurity 13 | 211448-81-6 | C18H28N4O29P6 |